⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockNetherlandsNasdaqGS

ARGX

argenx SE

Healthcare · Biotechnology

873.705USD

-2.0550 (-0.23%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on ARGX.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$7.32▼$8.1400
Next quarter$6.49▼$7.9400
Current year$28.28▲$27.8311
Next year$33.31▼$39.0520

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-09-30-$27.83$7.8+35.63 (+128.0%)
2026-06-30$6.19$7.32+1.13 (+18.2%)
2026-03-31$4.92$5.52+0.60 (+12.1%)
2025-12-31$6.11$8.02+1.91 (+31.2%)

Wall Street coverage

307 ratings from 34 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
Morgan StanleyMaintainedOverweight$1,140 $1,190Oct 23, 2026
GuggenheimMaintainedBuy$1,185 $1,120Oct 23, 2026
Wells FargoMaintainedOverweight$1,356 $1,336Oct 23, 2026
Evercore ISI GroupMaintainedOutperform$1,078 $1,090Oct 23, 2026
BairdMaintainedNeutral$823 $861Oct 23, 2026
RBC CapitalMaintainedOutperform$1,100 $1,025Oct 20, 2026
Wells FargoMaintainedOverweight$1,355 $1,356Oct 14, 2026
OppenheimerMaintainedOutperform$1,100 $1,038Oct 12, 2026
Evercore ISI GroupMaintainedOutperform$1,175 $1,078Oct 9, 2026
BairdMaintainedNeutral$932 $823Oct 9, 2026
WedbushReiteratedOutperform$1,150Sep 8, 2026
WedbushReiteratedOutperform$1,150Sep 3, 2026
Morgan StanleyMaintainedOverweight$1,230 $1,250Aug 31, 2026
UBSUpgraded from NeutralBuy$960 $1,400Aug 26, 2026
Wells FargoMaintainedOverweight$1,350 $1,415Aug 26, 2026
Truist SecuritiesMaintainedBuy$1,030 $1,095Aug 18, 2026
Morgan StanleyMaintainedOverweight$1,200 $1,230Aug 18, 2026
RBC CapitalMaintainedOutperform$1,025 $1,100Aug 18, 2026
CitizensMaintainedMarket Outperform$932 $1,200Aug 18, 2026
WedbushMaintainedOutperform$1,050 $1,150Aug 18, 2026
HC Wainwright & Co.MaintainedBuy$940 $1,202Aug 18, 2026
Piper SandlerMaintainedOverweight$1,075 $1,215Aug 17, 2026
WedbushMaintainedOutperform$1,000 $1,050Jul 28, 2026
BairdMaintainedNeutral$867 $932Jul 27, 2026
OppenheimerMaintainedOutperform$1,014 $1,037Jul 24, 2026

Analyst Notes

Sign in to write

No analyst notes on ARGX yet.

Top voices on ARGX

Members whose judged calls on ARGX have played out most reliably.

No settled calls on ARGX yet. Nobody has filed a call with a deadline on it.

A member is listed once they have three judged calls on a name.

Sign in to make a call

A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.

A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.

A member’s prediction, judged on price history · not investment advice

Analyst Ratings

22 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current713300Buy1.83
1 mo ago715300Buy1.84
2 mo ago715300Buy1.84
3 mo ago714300Buy1.83
Price target$1,143.95$861.00 – $1,353.00
+30.9% to target